IL-1 blockade in Schnitzler syndrome: Ex vivo findings correlate with clinical remission
John Ryan(National Institutes of Health), Anna Simon(Radboud University Nijmegen), Daniel L. Kastner(National Institutes of Health), Matthew G. Booty(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Lisa A. Beck(University of Rochester Medicine), Heleen D. de Koning(National Institutes of Health)
Cited by 88
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k